A sweeping new peer-reviewed study published in Genomic Psychiatry has introduced a concept that could reshape how psychiatrists and geneticists think about mental illness: genetic specificity.

Researchers used genomic structural equation modeling to separate schizophrenia-specific and shared bipolar genetic risks. Schizophrenia-unique variants were linked to lower IQ, while shared variants ...

Massive Swedish study of over two million people reveals that genetic risk for mental illness often points toward ...

Milsaperidone, a new chemical entity, is the major active metabolite of iloperidone (Fanapt) and had been demonstrated to be bioequivalent to iloperidone.

The FDA OKs pill schizophrenia and bipolar disorder treatment with Bysanti, a new atypical antipsychotic approved for adults.

Milsaperidone is an active metabolite of iloperidone ...

The biopharmaceutical company said Friday Bysanti tablets were approved for the acute treatment of manic or mixed episodes associated with bipolar I disorder, as well as for the treatment of ...